对治疗青光眼的局部前列腺素类型的全身不良药物事件:一项回顾性专注药监研究
1Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain. skannandr@gmail.com.
BMC ophthalmology
|December 31, 2024
概括
用于治疗青光眼的局部前列腺素类似物可以引起全身不良药物事件 (ADEs),特别是老年患者的过敏反应. 持续监测对于患者安全至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 眼科医生 眼科 眼科
- 药品安全 药品安全
背景情况:
- 前列腺素类似物是开角玻璃眼的主要治疗方法,有效降低眼内压力.
- 尽管局部应用,系统性不良药物事件 (ADEs) 已被记录.
- 这项研究研究了与局部前列腺素类似物相关的系统性ADEs.
研究的目的:
- 调查与局部前列腺素类似物相关的全身不良药物事件 (ADEs).
- 分析这些ADE的USFDA药物不良事件报告系统 (AERS) 的数据.
主要方法:
- 使用USFDA AERS数据 (2004年3月至2024年3月) 的回顾性药监测研究.
- 不成比例分析 (频率主义和贝叶斯主义) 应用于脱重复报告.
- 纳入报告,当局部前列腺素类似物是系统性ADEs的主要嫌疑人.
主要成果:
- 分析了30853份报告,主要涉及拉坦诺普罗斯特和比马托普罗斯特,主要是老年女性.
- 过敏反应是最常见的系统性ADE.
- 具体的ADEs因类似物而异:拉坦诺普罗斯特 (心脏事件),比马托普罗斯特 (黑色素瘤),塔夫洛普罗斯特 (死亡率更高,因果关系未被证明).
结论:
- 局部用前列腺素类似物与系统性ADEs有关,特别是在老年人和女性群体中.
- 过敏反应和心脏事件 (拉坦诺普罗斯特) 是关键问题.
- 虽然tafluprost的死亡率较高,但因果关系仍未确立;持续监测和针对患者的处方至关重要.
相关概念视频
01:19Pharmacovigilance
730
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
730
01:27Open Angle Glaucoma: Treatment
355
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
355
01:25Glaucoma: Overview
465
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
465
01:28Angle Closure Glaucoma: Treatment
360
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
360
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
97
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
97
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
296
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
296